SynRx Overview
- Year Founded
-
2022
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
SynRx General Information
Description
Developer of a novel therapeutic approach intended for targeted drug delivery. The company's platform utilizes living microorganisms loaded with therapeutic drugs, designed for precise delivery to tumor sites, and recognizes tumor characteristics, enabling healthcare businesses to achieve maximized therapeutic effects due to the delivery capabilities of living medicine.
Contact Information
Website
www.synrx.co.krCorporate Office
- Seoul
- South Korea
Corporate Office
- Seoul
- South Korea
SynRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 03-Feb-2025 | Completed | Out of Business | |||
| 3. Accelerator/Incubator | 01-May-2023 | Completed | Startup | |||
| 2. Seed Round | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
SynRx FAQs
-
When was SynRx founded?
SynRx was founded in 2022.
-
Where is SynRx headquartered?
SynRx is headquartered in Seoul, South Korea.
-
What industry is SynRx in?
SynRx’s primary industry is Drug Discovery.
-
Is SynRx a private or public company?
SynRx is a Private company.
-
What is SynRx’s current revenue?
The current revenue for SynRx is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process